This Study Evaluated the Safety of Awake Extubation in Children at Risk for Respiratory Events Undergoing General Anesthesia.

NCT06936761 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 425

Last updated 2025-04-20

No results posted yet for this study

Summary

The primary aim of this study was to evaluate the safety of awake extubation in children at risk for PRAEs undergoing general anesthesia. Specifically, this study seeks to compare the effects of sevoflurane and propofol induction on postoperative (emergence and recovery) respiratory outcomes in these patients. This study aims to provide insights that could enhance anesthesia protocols in pediatric populations with heightened respiratory risks by identifying potential differences in airway-related adverse events between the two agents.

Conditions

  • Respiratory Tract Infection

Interventions

DRUG

Propofol

This is an observational study about routines of anesthesia induction and extubation

DRUG

Sevoflurane

This is a retrospective evolution of anesthesia drugs used routinely in an anesthesia clinic.

Sponsors & Collaborators

  • Selcuk University

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2024-12-25
Completion
2024-12-31
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06936761 on ClinicalTrials.gov